Notable Reporting: What’s Humana Inc Upside After Reaching 52-Week High?

Notable Reporting: What's Humana Inc Upside After Reaching 52 Week High?

The stock of Humana Inc (NYSE:HUM) hit a new 52-week high and has $219.34 target or 6.00% above today’s $206.92 share price. The 9 months bullish chart indicates low risk for the $31.73B company. The 1-year high was reported on Nov, 23 by If the $219.34 price target is reached, the company will be worth $1.90B more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 778,091 shares traded hands. Humana Inc (NYSE:HUM) has risen 18.60% since April 21, 2016 and is uptrending. It has outperformed by 13.27% the S&P500.

Analysts await Humana Inc (NYSE:HUM) to report earnings on February, 8. They expect $2.17 earnings per share, up 49.66% or $0.72 from last year’s $1.45 per share. HUM’s profit will be $332.76M for 23.84 P/E if the $2.17 EPS becomes a reality. After $3.18 actual earnings per share reported by Humana Inc for the previous quarter, Wall Street now forecasts -31.76% negative EPS growth.

Humana Inc (NYSE:HUM) Ratings Coverage

Out of 7 analysts covering Humana (NYSE:HUM), 4 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 57% are positive. Humana has been the topic of 17 analyst reports since July 30, 2015 according to StockzIntelligence Inc. RBC Capital Markets maintained it with “Outperform” rating and $224 target price in Friday, July 22 report. The stock of Humana Inc (NYSE:HUM) earned “Buy” rating by Jefferies on Monday, July 18. On Friday, July 22 the stock rating was maintained by FBR Capital with “Mkt Perform”. The rating was initiated by JP Morgan on Wednesday, September 16 with “Overweight”. The company was maintained on Thursday, October 13 by RBC Capital Markets. The company was maintained on Thursday, July 30 by Barclays Capital. On Wednesday, December 16 the stock rating was initiated by Credit Suisse with “Neutral”. Barclays Capital maintained the stock with “Equal-Weight” rating in Thursday, August 4 report. On Tuesday, August 16 the stock rating was maintained by Credit Suisse with “Neutral”. The rating was maintained by Jefferies on Thursday, August 4 with “Buy”.

According to Zacks Investment Research, “Humana, Inc. is a health services company that facilitates the delivery of health care services through networks of providers to its medical members. The company’s products are marketed primarily through health maintenance organizations and preferred provider organizations that encourage or require the use of contracted providers. The company also offers various specialty products to employers, including dental, group life and workers’ compensation, and administrative services to those who self-insure their employee health plans.”

Insitutional Activity: The institutional sentiment decreased to 0.91 in 2016 Q2. Its down 0.19, from 1.1 in 2016Q1. The ratio turned negative, as 43 funds sold all Humana Inc shares owned while 172 reduced positions. 59 funds bought stakes while 178 increased positions. They now own 135.64 million shares or 4.91% less from 142.65 million shares in 2016Q1.
Blackrock Management Ltd Liability has 950,666 shares for 0.22% of their US portfolio. Price T Rowe Assocs Md has 13.87 million shares for 0.53% of their US portfolio. D E Shaw & Company Incorporated owns 2.11M shares or 0.7% of their US portfolio. Vigilant Management Ltd Limited Liability Company holds 1,750 shares or 0.06% of its portfolio. The Pennsylvania-based Veritable Limited Partnership has invested 0.02% in Humana Inc (NYSE:HUM). Tokio Marine Asset Management Ltd has invested 0.08% of its portfolio in Humana Inc (NYSE:HUM). Savant Capital Ltd Llc has invested 0.12% of its portfolio in Humana Inc (NYSE:HUM). Westpac Bk holds 49,038 shares or 0% of its portfolio. Pub Sector Pension Investment Board owns 69,242 shares or 0.14% of their US portfolio. Citadel Advsrs Llc reported 37,903 shares or 0.01% of all its holdings. Alpine Assocs Management Incorporated last reported 4.12% of its portfolio in the stock. Harvey Inv Communications Ltd Llc has 0.08% invested in the company for 2,000 shares. Swiss State Bank has invested 0.12% of its portfolio in Humana Inc (NYSE:HUM). Tcw Group Inc accumulated 10,950 shares or 0.01% of the stock. Tci Wealth Advsr has invested 0% of its portfolio in Humana Inc (NYSE:HUM).

Another recent and important Humana Inc (NYSE:HUM) news was published by which published an article titled: “Humana Distributes More Than $93 Million in Quality Payments to Providers …” on November 16, 2016.

HUM Company Profile

Humana Inc. (Humana), incorporated on July 27, 1964, is a health and well-being company. The Company’s medical and specialty insurance products allow members to access healthcare services primarily through its networks of healthcare providers. The Company’s divisions include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group segment consists of employer group commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary insurance benefits, as well as administrative services only (ASO) products. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, well-known provider services, home services and clinical programs, as well as services and capabilities to advance population health. The Other Businesses segment includes its closed-block long-term care insurance policies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment